Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

BofA cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Oppenheimer cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Alnylam Pharmaceuticals: An Unexpected Rival Trial Failure Improves The Core TTR Franchise Outlook - Seeking Alpha

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Rare skin disease gets first company-backed clinical trial as Quoin wins FDA clearance - Stock Titan

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

MacroGenics Completes $122.5 Million Sale Of GMP Manufacturing Operations To Bora Pharmaceuticals - Pulse 2.0

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Ionis Pharmaceuticals (IONS) Stock Slammed by Phase 3 Trial Results - TipRanks

news.google.com · 10 Jul 2026

Industry News External News

Daewoong Pharma receives most clinical trial approvals in 2016 - The Korea Herald

news.google.com · 09 Jul 2026

Google News – Cardiology External News

'We have an expansive view:' Kardigan CEO knits sharper trials, digital health into cardio strategy - Fierce Biotech

news.google.com · 09 Jul 2026

Google News – Oncology External News

Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma - Yahoo Finance

news.google.com · 09 Jul 2026

Google News – Clinical Trials External News

Awareness, access, and integrating clinical trial discussions into routine care - OncLive

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) - Arrowhead Pharmaceuticals, Inc.

news.google.com · 09 Jul 2026

Industry News External News

Natco Pharma approves investment up to ₹1,400 crore in wholly-owned subsidiary in South Africa - BusinessLine

news.google.com · 09 Jul 2026

Google News – Cardiology External News

Richard Kovacs explains key cardiac pharma trials at ACC 2025 - Cardiovascular Business

news.google.com · 09 Jul 2026

Google News – Cardiology External News

Trial Results: Low-Dose Colchicine Helps Treat Cardiovascular Disease - dicardiology.com

news.google.com · 09 Jul 2026

Google News – Oncology External News

Iteos Therapeutics seeks partners for cancer drug programs as Nasdaq-listed biotech advances trials - AD HOC NEWS

news.google.com · 09 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

BofA cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

Oppenheimer cuts Ionis Pharmaceuticals stock price target on trial miss - Investing.com

Alnylam Pharmaceuticals: An Unexpected Rival Trial Failure Improves The Core TTR Franchise Outlook - Seeking Alpha

Rare skin disease gets first company-backed clinical trial as Quoin wins FDA clearance - Stock Titan

MacroGenics Completes $122.5 Million Sale Of GMP Manufacturing Operations To Bora Pharmaceuticals - Pulse 2.0

Ionis Pharmaceuticals (IONS) Stock Slammed by Phase 3 Trial Results - TipRanks

Daewoong Pharma receives most clinical trial approvals in 2016 - The Korea Herald

'We have an expansive view:' Kardigan CEO knits sharper trials, digital health into cardio strategy - Fierce Biotech

Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma - Yahoo Finance

Awareness, access, and integrating clinical trial discussions into routine care - OncLive

Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) - Arrowhead Pharmaceuticals, Inc.

Natco Pharma approves investment up to ₹1,400 crore in wholly-owned subsidiary in South Africa - BusinessLine

Richard Kovacs explains key cardiac pharma trials at ACC 2025 - Cardiovascular Business

Trial Results: Low-Dose Colchicine Helps Treat Cardiovascular Disease - dicardiology.com

Iteos Therapeutics seeks partners for cancer drug programs as Nasdaq-listed biotech advances trials - AD HOC NEWS